Abstract
Lower urinary tract infection is the most common bacterial infections in a population of adult women. Recurrent infections are involved in a serious reduction in quality of life.
The main risk factor for female urinary infection is the colonization of the vagina and perineum uropathogen. Proper treatment of primary urinary tract infection and appropriate form of relapse prevention is very important.
The most common prophylactic treatment modality is a continuous low dose antimicrobial product, then used postcoital antibiotic therapy or immunomodulatory therapy. Women with urogenital atrophy in postmenopausal women with vaginal estrogen therapy recommended.